Authentikos Wealth Advisory’s BioMarin Pharmaceuticals BMRN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q4
Sell
-17
Closed -$1.5K 116
2023
Q3
$1.5K Buy
+17
New +$1.5K ﹤0.01% 468